new: FDA (U.S.) Approves Bevacizumab for Platinum-Sensitive Ovarian Cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, December 07, 2016

new: FDA (U.S.) Approves Bevacizumab for Platinum-Sensitive Ovarian Cancer



FDA Approves Bevacizumab for Platinum-Sensitive Ovarian Cancer
 Tuesday, Dec 06, 2016
  Specifically, the new indication supports the use of bevacizumab either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine chemotherapy, followed by bevacizumab alone, for patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, Genentech said.

0 comments :

Post a Comment

Your comments?